Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 9
July 2024
Volume 65, Issue 9
Open Access
ARVO Imaging in the Eye Conference Abstract  |   July 2024
Hypertransmission defect phenotypes and functional associations in eyes with neovascular age-related macular degeneration
Author Affiliations & Notes
  • Siqing Yu
    F Hoffmann-La Roche AG, Basel, Switzerland
  • Bjoern Titz
    F Hoffmann-La Roche AG, Basel, Switzerland
  • Mahnaz Parian-Scherb
    F Hoffmann-La Roche AG, Basel, Switzerland
  • Isabel Bachmeier
    F Hoffmann-La Roche AG, Basel, Switzerland
  • Philip Enders
    Universitatsklinikum Koln, Koln, Nordrhein-Westfalen, Germany
  • Lebriz Altay
    Universitatsklinikum Koln, Koln, Nordrhein-Westfalen, Germany
  • Michael Koss
    Eye Center Nymphenburger Höfe, Germany
  • Siamak Ansari Shahrezaei
    Karl Landsteiner Institute for Retinal Research and Imaging, Austria
  • Justus Garweg
    Berner Augenklinik, Bern, Switzerland and Department of Ophthalmology, Switzerland
  • Carl Glittenberg
    F Hoffmann-La Roche AG, Basel, Switzerland
  • Cathy Cukras
    F Hoffmann-La Roche AG, Basel, Switzerland
  • Andreas Maunz
    F Hoffmann-La Roche AG, Basel, Switzerland
  • Sascha Fauser
    F Hoffmann-La Roche AG, Basel, Switzerland
  • Footnotes
    Commercial Relationships   Siqing Yu, F. Hoffmann-La Roche (E); Bjoern Titz, F. Hoffmann-La Roche (E); Mahnaz Parian-Scherb, F. Hoffmann-La Roche (E); Isabel Bachmeier, F. Hoffmann-La Roche (E); Philip Enders, F. Hoffmann-La Roche (F); Lebriz Altay, AbbVie (R), Apellis (R), Bayer (R), F. Hoffmann-La Roche (F), F. Hoffmann-La Roche (R), Novartis (R); Michael Koss, F. Hoffmann-La Roche (C); Siamak Ansari Shahrezaei, AbbVie (C), Apellis (C), Bayer (F), Bayer (C), F. Hoffmann-La Roche (F), F. Hoffmann-La Roche (C), Novartis (C); Justus Garweg, AbbVie (C), Bayer (C), F. Hoffmann-La Roche (C), Novartis (C); Carl Glittenberg, F. Hoffmann-La Roche (E); Cathy Cukras, F. Hoffmann-La Roche (E); Andreas Maunz, F. Hoffmann-La Roche (E); Sascha Fauser, F. Hoffmann-La Roche (E)
  • Footnotes
    Support  This is a study supported by F Hoffmann-La Roche
Investigative Ophthalmology & Visual Science July 2024, Vol.65, PB0082. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Siqing Yu, Bjoern Titz, Mahnaz Parian-Scherb, Isabel Bachmeier, Philip Enders, Lebriz Altay, Michael Koss, Siamak Ansari Shahrezaei, Justus Garweg, Carl Glittenberg, Cathy Cukras, Andreas Maunz, Sascha Fauser; Hypertransmission defect phenotypes and functional associations in eyes with neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2024;65(9):PB0082.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To characterize hypertransmission defect (hyperTD) on en face optical coherence tomography (OCT) images in neovascular age-related macular degeneration (nAMD) and to examine its functional associations.

Methods : In this cross-sectional study, 97-line OCT volumes (Heidelberg Spectralis) from 118 treated nAMD eyes (mean treatment duration: 3.1 yrs) were collected. Reflectivity projection of a slab located 64 to 400 um below Bruch's membrane was manually inspected to identify regions of higher reflectivity (HyperTD). For eyes with hyperTD involving the foveal center, the reflectivity quality was classified into focal, diffuse or incipient (Fig. 1A). The corresponding foveal B scan was graded for the presence of the following 5 fovea center atrophic features (FCAF): outer nuclear layer thinning (ONLT), external limiting membrane disruption (ELMD), ellipsoid zone disruption (EZD), retinal pigment epithelium disruption (RPED), and hypertransmission into choroid (HTC). We analyzed the association of hyperTD phenotypes with presence of FCAFs and best corrected visual acuity (BCVA).

Results : HyperTD was not reproducibly gradable with sufficient confidence in 34 (28.8%) eyes due to large pigment epithelial detachment (PED) or subretinal hyperreflective material (SHRM). In the remaining 84 eyes, foveal-involving hyperTD was present in 56 (66.7%) eyes, which were classified as 8 (9.5%) focal, 25 (29.8%) diffuse and 23 (27.4%) incipient. Compared to incipient hyperTD, diffuse hyperTD were associated with more FCAFs (Fig. 1B) and lower BCVA (Fig. 1C), suggesting that diffuse hyperTD is associated with more advanced stages of macular atrophy.
Among the 5 FCAFs, HTC (61%) and EZD (62%) were the most, while RPED (24%) was the least observed. Each individual FCAF was significantly associated with worse BCVA (Fig. 2A). ONLT, ELMD, EZD and HTC correlated well with each other; Conversely, RPE disruption was less correlated with the other 4 (Fig. 2B). Presence of ≥3 FCAFs started to show a significant association with worse BCVA compared to absence of any FCAF (Fig. 2C).

Conclusions : HyperTD was commonly observed in nAMD eyes. Diffuse hyperTD was associated with more FCAFs and poorer BCVA, suggesting more advanced stages of macular atrophy. However, hyperTD assessment was limited when large PED or SHRM was present, which was seen in more than a quarter of the eyes.

This abstract was presented at the 2024 ARVO Imaging in the Eye Conference, held in Seattle, WA, May 4, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×